Stelara
Active Ingredient(s): UstekinumabFDA Approved: * September 25, 2009
Pharm Company: * CENTOCOR ORTHO BIOTECH INC
Category: Immunosuppressive
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Stelara Overview
Ustekinumab,[5] sold under the brand name Stelara®, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,[6] targeting both IL-12 and IL-23. Stelara® is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not respo...
Read more Stelara DetailsDetails May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ustekinumab
Recent Stelara Forums:
Stelara Study
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past? If so, The Frankel Group, a life science strategy consulting firm in New York City, is conducting market research to understand the experiences patients have had with biologic therapies, including Enbrel, Humira, Remicade, or Stelara. We are currently looking for patients to participate in a 30 minute market research telephone interview, for a $50 honorarium. Interviews are completely confidential and we will never share your name or information. If you are interested in participating in this market research study, please contact [email protected] or 212-896-1662 for additional details. Thank you! ## Hi Rita - how long is this study running for? Do respondents ...
Updated
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past? If so, The Frankel Group, a life science strategy consulting firm in New York City, is conducting market research to understand the experiences patients have had with biologic therapies, including Enbrel, Humira, Remicade, or Stelara. We are currently looking for patients to participate in a 30 minute market research telephone interview, for a $50 honorarium. Interviews are completely confidential and we will never share your name or information. If you are interested in participating in this market research study, please contact [email protected] or 212-896-1662 for additional details. Thank you! ## Hi Rita - how long is this study running for? Do respondents ...
Updated
Possible Dosages for this and Related Drugs:
Ustekinumab
- Injection: 130mg/26ml, 45mg/0.5ml, 90mg/1ml
NDC Database Records for Stelara: (3 results)
Sorted by National Drug Code- 57894-054 Stelara 130 mg/26ml Intravenous Solution by Janssen Biotech, Inc.
- 57894-060 Stelara 45 mg/.5ml Subcutaneous Injection, Solution by Janssen Biotech, Inc.
- 57894-061 Stelara 90 mg/ml Subcutaneous Injection, Solution by Janssen Biotech, Inc.
Other drugs which contain Ustekinumab or a similar ingredient: (1 result)
Related Stelara Topics:
Stelara Study
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past... 3 replies
Are you a patient with moderate to severe psoriasis that is currently taking or has taken biologic therapies in the past... 3 replies